🍂 Enjoy the Fall Season! 🍂
MindTheDesk

Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive

Global - Asia Archived • July 22, 2026 • 2 views
Trump’s 200% tariffs on pharma: Why India’s generic medicines could still remain competitive
US President Donald Trump on Tuesday announced the final stage of his pharmaceutical tariff plan, under which imported generic medicines will continue to enter the US without duties until August 1, 2028.
Source: https://timesofindia.indiatimes.com/rssfeedstopstories.cms - Read Original
"We build AI or anything ICST"
"Camping the Easyway"

Discussion (0)

Please log in to post a comment.

No comments yet. Be the first to share your thoughts!

Sponsored
"Monetize your website or boost your business with Code-Oryx. Join the network today!"
"Get your business promoted today."